Literature DB >> 27751628

Replacing Phosphorus-Containing Food Additives With Foods Without Additives Reduces Phosphatemia in End-Stage Renal Disease Patients: A Randomized Clinical Trial.

Margareth Lage Leite de Fornasari1, Yvoty Alves Dos Santos Sens2.   

Abstract

OBJECTIVE: The purpose of the study was to verify the effects of replacing phosphorus-containing food additives with foods without additives on phosphatemia in end-stage renal disease (ESRD) patients.
DESIGN: Randomized clinical trial.
SETTING: Adult patients on hemodialysis for ≥6 months at a single center.
SUBJECTS: A total of 134 patients with phosphorus levels of >5.5 mg/dL were included and were randomized into an intervention group (n = 67) and a control group (n = 67). INTERVENTION: The IG received individual orientation to replace processed foods that have phosphorus additives with foods of similar nutritional value without these additives. The CG received only the nutritional orientation given before the study. Clinical laboratory data, nutritional status, energy and protein intake, and normalized protein nitrogen appearance (nPNA) were evaluated at the beginning of the study and after 90 days.
RESULTS: There was no initial difference between the groups in terms of serum phosphorus levels, nutritional status, and energy intake. After 3 months, there was a decline in phosphorus levels in the IG (from 7.2 ± 1.4 to 5.0 ± 1.3 mg/dL, P < .001), but there was no significant difference in the CG (from 7.1 ± 1.2 to 6.7 ± 1.2 mg/dL, P = .65). In the IG, 69.7% of the patients reached the serum phosphorus target of ≤5.5 mg/dL; however, only 18.5% of the CG subjects reached this level (P < .001).
CONCLUSION: At the end, there was no difference between the two groups in terms of nutritional status, energy intake, protein intake, and nPNA. The replacing phosphorus-containing food additives with foods without additives reduced serum phosphorus without interfering in the nutritional status of ESRD patients.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27751628     DOI: 10.1053/j.jrn.2016.08.009

Source DB:  PubMed          Journal:  J Ren Nutr        ISSN: 1051-2276            Impact factor:   3.655


  9 in total

1.  A new look at phosphorus intake: what do we eat here is what they eat there?

Authors:  Christiane Ishikawa Ramos; Lilian Cuppari
Journal:  J Bras Nefrol       Date:  2019-01-24

Review 2.  Effects of Excessive Dietary Phosphorus Intake on Bone Health.

Authors:  Colby J Vorland; Elizabeth R Stremke; Ranjani N Moorthi; Kathleen M Hill Gallant
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

Review 3.  Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease.

Authors:  Ezequiel Bellorin-Font; George Vasquez-Rios; Kevin J Martin
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

Review 4.  The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease.

Authors:  Jiameng Li; Liya Wang; Mei Han; Yuqin Xiong; Ruoxi Liao; Yupei Li; Si Sun; Anil Maharjan; Baihai Su
Journal:  Nutr Diabetes       Date:  2019-04-03       Impact factor: 5.097

Review 5.  FGF23 and Phosphate-Cardiovascular Toxins in CKD.

Authors:  Isabel Vogt; Dieter Haffner; Maren Leifheit-Nestler
Journal:  Toxins (Basel)       Date:  2019-11-06       Impact factor: 4.546

6.  Control of hyperphosphatemia and maintenance of calcemia in CKD.

Authors:  Aluizio Barbosa Carvalho; Fabiana Baggio Nerbass; Lilian Cuppari
Journal:  J Bras Nefrol       Date:  2021-12-03

7.  Effect of Phosphate-Specific Diet Therapy on Phosphate Levels in Adults Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis.

Authors:  David E St-Jules; Mary R Rozga; Deepa Handu; Juan Jesus Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2020-12-31       Impact factor: 8.237

Review 8.  The Importance of Phosphate Control in Chronic Kidney Disease.

Authors:  Ken Tsuchiya; Taro Akihisa
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

Review 9.  Intestinal Phosphorus Absorption in Chronic Kidney Disease.

Authors:  Elizabeth R Stremke; Kathleen M Hill Gallant
Journal:  Nutrients       Date:  2018-09-23       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.